A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia. Kuter DJ, Miura K, Patriarca A, Pulanic D, et al. N Engl J Med 2026;394:1388-1398.

Read + Share

Amedeo Smart

Independent Medical Education

Kuter DJ, Miura K, Patriarca A, Pulanic D, et al. A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia. N Engl J Med 2026;394:1388-1398.
PMID: 41950473